References
- Ball, J. C., Ross, A., & Jaffe, J. H (1989). Cocaine and heroin use by methadone maintenance patients. NIDA Research Monograph, 95, 328. https://pubmed.ncbi.nlm.nih.gov/2640981/
- Boehnke, K. F., Litinas, E., & Clauw, D. J. (2016). Medical cannabis use is associated with decreased opiate medication use in a retrospective cross-sectional survey of patients with chronic pain. The Journal of Pain : Official Journal of the American Pain Society, 17(6), 739–744. https://doi.org/https://doi.org/10.1016/j.jpain.2016.03.002
- Cullen, W., Kelly, Y., Stanley, J., Langton, D., & Bury, G. (2005). Experience of hepatitis C among current or former heroin users attending general practice. Irish Medical Journal, 98(3), 73–74. https://pubmed.ncbi.nlm.nih.gov/15869062/
- Darke, S. Self-report among injecting drug users: A review. (1998). Drug and Alcohol Dependence, 51(3), 253–263. discussion 267-8. https://doi.org/https://doi.org/10.1016/S0376-8716(98)00028-3
- Eiroa-Orosa, F. J., Haasen, C., Verthein, U., Dilg, C., Schafer, I., & Reimer, J. (2010). Benzodiazepine use among patients in heroin-assisted vs. methadone maintenance treatment: Findings of the German randomized controlled trial. Drug and Alcohol Dependence, 112(3), 226–233. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2010.06.013
- Jones, C. M., Paulozzi, L. J., & Mack, K. A. (2014). Alcohol involvement in opioid pain reliever and benzodiazepine drug abuse–related emergency department visits and drug-related deaths—United States, 2010. MMWR. Morbidity and Mortality Weekly Report, 63(40), 881–885. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6340a1.htm
- Kapur, B. M., Hutson, J. R., Chibber, T., Luk, A., & Selby, P. (2011). Methadone: A review of drug–drug and pathophysiological interactions. Critical Reviews in Clinical Laboratory Sciences, 48(4). https://doi.org/https://doi.org/10.3109/10408363.2011.620601
- Kerr, T., Fairbairn, N., Tyndall, M., Marsh, D., Li, K., Montaner, J., & Wood, E. (2007). Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users. Drug and Alcohol Dependence, 87(1), 39–45. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2006.07.009
- Kerr, T., Small, W., Johnston, C., Li, K., Montaner, J. S., & Wood, E. (2008). Characteristics of injection drug users who participate in drug dealing: Implications for drug policy. Journal of Psychoactive Drugs, 40(2), 147–152. https://doi.org/https://doi.org/10.1080/02791072.2008.10400624
- Lake, S., Kerr, T., Nosova, E., Milloy, M., Wood, E., & Debeck, K. (2018). Patterns of non-injection drug use associated with injection cessation among street-involved youth in Vancouver, Canada. Journal of Urban Health, 95(1), 1–11. https://doi.org/https://doi.org/10.1007/s11524-017-0212-8
- Lake, S., Kerr, T., Werb, D., Haines-Saah, R., Fischer, B., Thomas, G., Walsh, Z., Ware, M. A., Wood, E., & Milloy, M.-J. (2019). Guidelines for public health and safety metrics to evaluate the potential harms and benefits of cannabis regulation in Canada. Drug and Alcohol Review, 38(6), 606–621. https://doi.org/https://doi.org/10.1111/dar.12971
- Lucas, P., Baron, E. P., & Jikomes, N. (2019). Medical cannabis patterns of use and substitution for opioids & other pharmaceutical drugs, alcohol, tobacco, and illicit substances; results from a cross-sectional survey of authorized patients. Harm Reduction Journal, 16(1), 9. https://doi.org/https://doi.org/10.1186/s12954-019-0278-6
- Lucas, P., & Walsh, Z. (2017). Medical cannabis access, use, and substitution for prescription opioids and other substances: A survey of authorized medical cannabis patients. International Journal of Drug Policy, 42(April), 30–35. https://doi.org/https://doi.org/10.1016/j.drugpo.2017.01.011
- Lucas, P., Walsh, Z., Crosby, K., Callaway, R., Belle-Isle, L., Kay, R., Capler, R., & Holtzman, S. (2016). Substituting cannabis for prescription drugs, alcohol and other substances among medical cannabis patients: The impact of contextual factors. Drug and Alcohol Review, 35(3), 326–333. https://doi.org/https://doi.org/10.1111/dar.12323
- Naji, L., Dennis, B. B., Bawor, M., Plater, C., Pare, G., Worster, A., Varenbut, M., Daiter, J., Marsh, D. C., Desai, D., Thabane, L., & Samaan, Z. (2016). A prospective study to investigate predictors of relapse among patients with opioid use disorder treated with methadone. Substance Abuse : Research and Treatment, 10, 9–18. https://doi.org/https://doi.org/10.4137/SART.S37030
- Nyamathi, A., Cohen, A., Marfisee, M., Shoptaw, S., Greengold, B., De Castro, V., George, D., & Leake, B. (2009). Correlates of alcohol use among methadone-maintained adults. Drug and Alcohol Dependence, 101(1–2), 124–127. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2008.10.008
- Pacini, M., Maremmani, A. G. I., Ceccanti, M., & Maremmani, I. (2015). Former heroin-dependent alcohol use disorder patients. Prevalence, addiction history and clinical features. Alcohol and Alcoholism, 50(4), 451–457. https://doi.org/https://doi.org/10.1093/alcalc/agv028
- Reiman, A., Welty, M., & Solomon, P. (2017). Cannabis as a substitute for opioid-based pain medication: Patient self-report. Cannabis and Cannabinoid Research, 2(1), 160–166. https://doi.org/https://doi.org/10.1089/can.2017.0012
- Ryder, N., Cullen, W., Barry, J., Bury, G., Keenan, E., & Smyth, B. P. (2009). Prevalence of problem alcohol use among patients attending primary care for methadone treatment. BMC Family Practice, 10(1), 42. https://doi.org/https://doi.org/10.1186/1471–2296-10-42
- Socias, M. E., Kerr, T., Wood, E., Dong, H., Lake, S., Hayashi, K., Debeck, K., Jutras-Aswad, D., Montaner, J., & Milloy, M.-J. (2017). Intentional cannabis use to reduce crack cocaine use in a Canadian setting: A longitudinal analysis. Addictive Behaviors, 72(September), 138–143. https://doi.org/https://doi.org/10.1016/j.addbeh.2017.04.006
- Soyka, M. (2015). Alcohol use disorders in opioid maintenance therapy: Prevalence, clinical correlates and treatment. European Addiction Research, 21(2), 78–87. https://doi.org/https://doi.org/10.1159/000363232
- Staiger, P. K., Richardson, B., Long, C., Carr, V., & Marlatt, G. A. (2013). Overlooked and underestimated? Problematic alcohol use in clients recovering from drug dependence. Addiction, 108(7), 1188–1193. https://doi.org/https://doi.org/10.1111/j.1360-0443.2012.04075.x
- Strathdee, S. A. (1998). Barriers to use of free antiretroviral therapy in injection drug users. JAMA, 280(6), 547–549. https://doi.org/https://doi.org/10.1001/jama.280.6.547
- Wood, E., Hogg, R. S., Bonner, S., Kerr, T., Li, K., PALEPU, A., Guillemi, S., Schechter, M. T., & Montaner, J. S. (2004). Staging for antiretroviral therapy among HIV-infected drug users. JAMA, 292(10), 1175–1177. https://doi.org/https://doi.org/10.1001/jama.292.10.1175-b